Search Results - Polyzois Makras

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy

    Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy by Gregory Kaltsas, Polyzois Makras

    Published 2010
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues

    Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues by Gregory Kaltsas, Dimitrios Papadogias, Polyzois Makras, Ashley Grossman

    Published 2005
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis

    THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis by Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Polyzois Makras

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures

    Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures by Maria P. Yavropoulou, Athanasios D. Anastasilakis, Polyzois Makras, Dimitrios Tsalikakis, Maria Grammatiki, John G. Yovos

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review

    Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review by Athanasios D. Anastasilakis, Polyzois Makras, Maria P. Yavropoulou, Gaia Tabacco, Anda Mihaela Naciu, Andrea Palermo

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial

    Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinic... by Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Athina Gkiomisi, Ilias Bisbinas, Spyridon Gerou, Polyzois Makras

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment

    Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment by Athanasios D. Anastasilakis, Maria P. Yavropoulou, Polyzois Makras, G Sakellariou, Fotini Papadopoulou, Spyridon Gerou, Socrates E. Papapoulos

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases

    Clinical Features of 24 Patients With Rebound‐Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases by Athanasios D. Anastasilakis, Stergios A. Pοlyzos, Polyzois Makras, Bérengère Aubry‐Rozier, Stella Kaouri, Olivier Lamy

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial

    Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial by Athanasios D. Anastasilakis, Socrates E. Papapoulos, Stergios A. Pοlyzos, Natasha M. Appelman‐Dijkstra, Polyzois Makras

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal Osteoporosis

    Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal Osteoporosis by Athanasios D. Anastasilakis, Polyzois Makras, Maria Pikilidou, Symeon Tournis, Konstantinos Makris, Ilias Bisbinas, O. Tsave, John G. Yovos, Maria P. Yavropoulou

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation

    The Duration of Denosumab Treatment and the Efficacy of Zoledronate to Preserve Bone Mineral Density After Its Discontinuation by Polyzois Makras, Natasha M. Appelman‐Dijkstra, Socrates E. Papapoulos, Sandra van Wissen, Elizabeth M. Winter, Stergios A. Pοlyzos, Maria P. Yavropoulou, Athanasios D. Anastasilakis

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

    Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 1... by Peyman Hadji, Νικόλαος Παπαϊωάννου, Evelien Gielen, Maurille Feudjo Tepie, E Zhang, Isolde Frieling, Piet Geusens, Polyzois Makras, Heinrich Resch, Gerd Möller, L. Kalouche-Khalil, Astrid Fahrleitner‐Pammer

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium

    Factors associated with high 24-month persistence with denosumab: results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, G... by Astrid Fahrleitner‐Pammer, Νικόλαος Παπαϊωάννου, Evelien Gielen, Maurille Feudjo Tepie, C. Toffis, Isolde Frieling, Piet Geusens, Polyzois Makras, Ewald Boschitsch, J. Callens, Athanasios D. Anastasilakis, Christopher Niedhart, Heinrich Resch, L. Kalouche-Khalil, Peyman Hadji

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net

    Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net by Michael Girschikofsky, Maurizio Aricò, Diego Castillo, Anthony C. Chu, C. Doberauer, J Fichter, Julien Haroche, Gregory Kaltsas, Polyzois Makras, Angelo Valerio Marzano, Mathilde de Menthon, Oliver Micke, Emanuela Passoni, Heinrich Seegenschmiedt, Abdellatif Tazi, Kenneth L. McClain

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review

    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review by Manju Chandran, Kristina Åkesson, M K Javaid, Nicholas C. Harvey, Robert D. Blank, Maria Luisa Brandi, Thierry Chevalley, Paolo Cinelli, Cyrus Cooper, Willem F. Lems, George P. Lyritis, Polyzois Makras, Julien Paccou, Dominique D. Pierroz, M. Sosa Henríquez, Thierry Thomas, Stuart Silverman, Kristina Åkesson, Robert D. Blank, Maria Luisa Brandi, Derrick Chan, Manju Chandran, Thierry Chevalley, Cyrus Cooper, Patrice Fardellone, Julio Fernandes, Stefan Goemaere, Nicholas C. Harvey, Gerold Holzer, M K Javaid, Willem F. Lems, Michael Lewiecki, George P. Lyritis, Polyzois Makras, Nicola Napoli, Julien Paccou, Stuart Silverman, M. Sosa Henríquez, Thierry Thomas

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

    International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults by Gaurav Goyal, Abdellatif Tazi, Ronald S. Go, Karen L. Rech, Jennifer Picarsic, Robert Vassallo, Jason R. Young, Christian W. Cox, Jan van Laar, Michelle L. Hermiston, Xinxin Cao, Polyzois Makras, Gregory Kaltsas, Julien Haroche, Matthew Collin, Kenneth L. McClain, Eli L. Diamond, Michael Girschikofsky

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: